United States Drugs of Abuse Testing Market, 2019 to 2023: Supplier Shares & Segment Forecasts by Test, Competitive Intelligence for Suppliers - ResearchAndMarkets.com

DUBLIN--()--The "US Drugs of Abuse Testing Market, 2019-2023: Supplier Shares and Segment Forecasts by Test, Competitive Intelligence for Suppliers" report has been added to ResearchAndMarkets.com's offering.

This new 262 page report from the author provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.

During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.

Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

This report is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.

Key Topics Covered

Introduction

Worldwide Market and Technology Overview

A. Major Drugs of Abuse

1. Overview

2. Test Methodologies

3. Amphetamines

4. Barbiturates

5. Benzodiazepines

6. Cannabinoids/Marijuana

7. Cocaine

8. Lysergic Acid Diethylamide (LSD)

9. Methadone

10. Methaqualone

11. Opiates

12. Phencyclidine

13. Tricyclic Antidepressants

B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers manufactured by Abaxis, Abbott, Alere/Inverness, Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba, Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers

C. Major In Vitro Diagnostic Technologies and Their Potential Applications

1. Monoclonal and Polyclonal Antibodies

2. Immunoassays

a. Technological Principle

d. Chemiluminescence

c. Enzyme Immunoassays (EIA)

Overview

ELISA

EMIT

Electrochemical

d. Radioimmunoassays (RIA)

e. Immunoprecipitation

f. Affinity Chromatography

3. Tandem Mass Spec

4. IT and Automation

5. Dry Chemistry

6. Biosensors

D. Market Size, Growth and Major Supplier Shares

Alternative Market Penetration Strategies

a. Internal Development

b. Collaborative Arrangements

c. University Contracts

d. Distribution Strategies for Decentralized

Testing Markets

1. Marketing Approaches

2. Product Complexity

3. Customer Preference

4. Established Suppliers

5. Emerging Suppliers

6. Major Types of Distributors

7. Market Segmentation

Potential Market Entry Barriers and Risks

a. Market Maturity

b. Cost Containment

c. Competition

d. Technological Edge and Limitations

e. Patent Protection

f. Regulatory Constraints

g. Decentralized Testing Market Challenges

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • bioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken Chemical
  • Fujirebio
  • Grifols
  • Instrumentation Laboratory/Werfen
  • Kyowa Medex
  • Ortho-Clinical Diagnostics
  • PerkinElmer
  • Quest Diagnostics
  • Roche
  • Siemens Healthineers
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako

For more information about this report visit https://www.researchandmarkets.com/r/h27m9

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Abuse Screening

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Abuse Screening